This single-receptor activation slows gastric emptying, reduces appetite signaling in the brain, improves insulin sensitivity, and creates a sustained feeling of fullness that makes caloric restriction feel almost effortless for many users
If your appetite suppression timeline differs significantly from expectationsor if you experience concerning side effectscontact your care team immediately for guidance
N Engl J Med 377:12281239 Hernandez AF, Green JB, Janmohamed S et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
GLP-1 medication works to suppress food noise
7 According to 2023 CDC data, in the United States 40.1 million people have diabetes, with type 2 diabetes representing 90% to 95%, or an estimated 36 38 million people living with type 2 diabetes, making it the most common form of the disease